A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors

Conditions

• Neoplasms
• Carcinoma, Hepatocellular
• Carcinoma, Non-Small-Cell Lung
• Liver Neoplasms

Interventions

• DRUG: AST-201

Sponsor

Aptamer Sciences, Inc.

Collaborators

• [object Object]
• [object Object]
• [object Object]
• [object Object]